NFB-13. TRAMETINIB FOR PLEXIFORM NEUROFIBROMA AND RECURRENT LOW-GRADE GLIOMA

BACKGROUND: Based on early clinical efficacy data, Seattle Children’s established a standard clinical practice for MEK inhibitor therapy for children with plexiform neurofibroma (PN) or recurrent low-grade glioma (LGG). METHODS: Data were collected under an IRB-approved retrospective chart review. T...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Sato, Aimee, Millard, Nathan, Perez, Francisco, Vitanza, Nicholas, Leary, Sarah
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Neurofibromatosis
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715321/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.616
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia